Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT

Overview of attention for article published in Journal of Hematology & Oncology, March 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

twitter: 18 X users

Citations

dimensions_citation: 137 Dimensions

Readers on

mendeley: 82 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 23 X posts from 18 X users, with an upper bound of 22,343 followers.

PTCy platform for GVHD prophylaxis in matched donor allos dissect GVHD from GVL producing low cGVHD rates. Yet, aGVHD can be a problem which is abrogated by combining Tac+MMF from d+5. Ongoing phase 3 trial results awaited but it seems we are on a roll.

23 Jun 2018

Reply Repost Favourite

@TheEBMT ALWP https://t.co/hxxHaw3qOD

20 May 2018

Reply Repost Favourite

RT @Colombianne: PT-Cy + 2 inmunosuppressive drugs better that PT-Cy alone for reduction of #cGVHD. #AlloSCT 🤔 Post-transplant cyclophosph…

05 Apr 2018

Reply Repost Favourite

RT @Colombianne: PT-Cy + 2 inmunosuppressive drugs better that PT-Cy alone for reduction of #cGVHD. #AlloSCT 🤔 Post-transplant cyclophosph…

30 Mar 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 19 additional X posts.